Canature Health Technology Group
Launch date
Employees
Market cap
$408m
Enterprise valuation
$429m (Public information from Sep 2024)
Share price
CNY4.96 300272.SZ
Shanghai Shanghai (HQ)
Financials
Estimates*
| CNY | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 1.1b | 1.2b | 1.5b | 1.7b | 1.7b | 14.5b |
| % growth | - | 12 % | 28 % | 10 % | 1 % | - |
| EBITDA | 213m | 205m | 219m | 229m | 269m | - |
| % EBITDA margin | 20 % | 17 % | 14 % | 14 % | 16 % | - |
| Profit | 101m | 26.4m | 105m | 92.7m | 132m | - |
| % profit margin | 10 % | 2 % | 7 % | 6 % | 8 % | - |
| R&D budget | 18.8m | 35.9m | 54.6m | 66.8m | 67.4m | - |
| R&D % of revenue | 2 % | 3 % | 4 % | 4 % | 4 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
